The Internet of Things (IoT) can change the way patients are monitored. This isn’t just a new data stream to combine with existing data, it’s a new way of thinking that could change clinical trials and the pharmaceutical industry as a whole, according to Medidata’s co-founder Glen de Vries.
IoT Data Could Plug Critical Gap In Pharmaceutical Industry, Says Medidata Cofounder
